PRESS RELEASE: Aquarius Population Health wins a prestigious SBRI grant from Innovate UK

Work has begun to develop a digital value proposition tool for a novel rapid sexually transmitted infection (STI) test

London, UK, 14 August 2017

Aquarius Population Health, a leading independent health economics consultancy, has recently been awarded an 18-month Innovate UK grant in collaboration with Atlas Genetics Ltd and the Applied Diagnostic Research and Evaluation Unit at St George’s University of London (total £2,000,000). The funding will be used to develop evidence for health services to support the introduction of a new rapid diagnostic test. In 30-minutes the test can diagnose multiple sexually transmitted infections including chlamydia and gonorrhoea – infections which could take up to a week to diagnose using the current laboratory testing systems.

Continue reading

Evaluating the use AMR POCT in treatment of gonorrhoea

Aquarius Population Health recently worked with the Applied Diagnostic Research & Evaluation Unit (ADREU) at St. Georges, University of London, to assess the cost-effectiveness of six hypothetical strategies for using antimicrobial resistance point-of-care testing to guide the treatment of gonorrhoea.  Our findings were presented at the STI & HIV World Congress in Rio de Janeiro, Brazil. [Wednesday 12th July, Session 15: STI/HIV testing and management].

Continue reading

Aquarius Population Health presents the breast cancer diagnostic pathway at ISPOR Milan

Our Managing Director, Dr Elisabeth Adams, will be presenting “Mapping the diagnostic pathway for breast cancer in England and comparison to Europe” at the International Society for Pharmacoeconomics and Outcomes Research (ISPOR) Milan which runs from the 7 – 11 November, 2015.

Continue reading

Rapid on-demand testing of HPV and cervical cancer prevention: IPV Conference in Lisbon

Our managing director, Dr Elisabeth Adams, is presenting two posters at the 30th annual International Papillomavirus Conference  in Lisbon, Portugal.  The first poster, “Exploring the value of a rapid, on-demand test for the detection of human papillomavirus”, is a detailed look at the current patient pathways for cervical screening programmes, and key opinion leaders’ views on the impact a rapid diagnostic would have on the health and overall wellbeing of women.

Continue reading